Skip to main content
logo
Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
108.35
-6.31 (-5.50%)
At close: Jul 31, 2026, 4:00 PM EDT
108.25
-0.10 (-0.09%)
After-hours: Jul 31, 2026, 7:42 PM EDT

Monopar Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
72643713453140
Market Cap Growth
175.83%225.49%2549.34%-83.48%-24.13%-42.31%
Enterprise Value
588.55296.7574.04-2.217.5720.14
Last Close Price
108.3565.3022.001.7011.8516.05

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
5.363.172.440.913.042.14
P/TBV Ratio
6.243.511.520.842.992.11

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
---0.25--
EV/EBIT Ratio
---0.25--
EV/FCF Ratio
---0.28--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.00000.000
Net Debt / Equity Ratio
-1.01-1.02-1.09-1.30-1.30-1.07
Net Debt / EBITDA Ratio
7.348.403.730.821.242.23
Net Debt / FCF Ratio
13.7211.499.400.931.812.78
Quick Ratio
55.9451.3311.464.134.1912.85
Current Ratio
56.0451.3511.474.174.2112.98
Return on Equity (ROE)
-10.97%-14.22%-51.42%-107.19%-72.44%-52.57%
Return on Assets (ROA)
-13.43%-16.62%-47.79%-85.86%-62.44%-48.82%
Return on Invested Capital (ROIC)
-7561.74%-13105.60%-255602.00%-23908.90%-34418.50%-26510.30%
Return on Capital Employed (ROCE)
-13.68%-17.31%-53.32%-112.60%-72.57%-52.71%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-64.59%-95.53%-37.08%-8.70%-1.98%-13.81%
Total Shareholder Return
-64.59%-95.53%-37.08%-8.70%-1.98%-13.81%
SEC Filings: 10-K · 10-Q